| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$57 |
SPP Deadline Approaching
|
2 Sep 2025 9:54AM |
$0.059 |
$0.140 |
risen by
137.29%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$19 |
1H FY25 Results Investor Presentation
|
2 Sep 2025 9:52AM |
$0.220 |
$0.350 |
risen by
59.09%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 4% to $13.7 million.
- Annual Recurring Revenue (ARR) grew by 11% to $32.8 million.
- Software ARR increased by 20%, focusing on IMEXHS Enterprise and Cloud.
- Radiology ARR increased by 6%, with EBITDA improving to $0.3 million.
- Cost and margin improvement initiatives were implemented.
- Launch of the AI-enhanced RIS-PACS suite, Aquila+.
- Guidance for FY25 includes revenue growth and improved EBITDA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$19 |
1H FY25 Results Investor Presentation
|
2 Sep 2025 9:52AM |
$0.220 |
$0.350 |
risen by
59.09%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Financial performance for 1H FY25 presented in Australian Dollars.
- Non-IFRS financial measures, such as EBITDA, are used.
- Caution advised for interpreting non-IFRS information.
- Focus on operational performance and strategic developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Scalare Partners Successfully Closes Share Purchase Plan
|
2 Sep 2025 9:51AM |
$0.105 |
$0.072 |
fallen by
31.43%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Scalare Partners Holdings Limited (ASX: SCP) closed its Share Purchase Plan (SPP), raising $90,848 before costs.
- The SPP followed a $3.0 million Placement to institutional and sophisticated investors, raising a total of $3.09 million.
- Eligible shareholders could subscribe for up to $30,000 of new shares at $0.12 each, with one free attaching option exercisable at $0.18 expiring in two years.
- Funds will be used for the acquisition of Tank Stream Labs, investment in new portfolio companies, working capital, and offer costs.
- Allotment of new shares is expected on or around 8 September 2025, subject to shareholder approval at an EGM on 3 September 2025.
- Scalare Partners focuses on empowering technology founders and is involved in initiatives like Tech Ready Women and the Australian Technologies Competition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Scalare Partners Successfully Closes Share Purchase Plan
|
2 Sep 2025 9:51AM |
$0.105 |
$0.072 |
fallen by
31.43%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Scalare Partners successfully closes Share Purchase Plan.
- Raised $90,848 through SPP after $3.0 million Placement.
- Total funds raised are $3.09 million.
- SPP shares priced at $0.12 with a $0.18 attaching option.
- Funds for Tank Stream Labs acquisition and new investments.
- Share allotment around 8 September 2025.
- Subject to shareholder approval at EGM on 3 September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fidelity Australian High Conviction Active ETF (FHCO) |
Financials |
$2 |
Units on Issue, Applications, Redemptions & ETD - 08.2025
|
2 Sep 2025 9:51AM |
$8.800 |
$7.890 |
fallen by
10.34%
|
|
| Fidelity India Active ETF (FIIN) |
Financials |
$6 |
Units on Issue, Applications, Redemptions & ETD - 08.2025
|
2 Sep 2025 9:51AM |
$9.160 |
$7.450 |
fallen by
18.67%
|
|
| Fidelity Asia Active ETF (FASI) |
Financials |
$29 |
Units on Issue, Applications, Redemptions & ETD - 08.2025
|
2 Sep 2025 9:51AM |
$11.510 |
$11.750 |
risen by
2.09%
|
|
| Fidelity Global Future Leaders Active ETF (FCAP) |
Financials |
$7 |
Units on Issue, Applications, Redemptions & ETD - 08.2025
|
2 Sep 2025 9:51AM |
$11.790 |
$11.710 |
fallen by
0.68%
|
|
| Fidelity Global Emerging Markets Fund (Managed Fund) (FEMX) |
Financials |
$187 |
Units on Issue, Applications, Redemptions & ETD - 08.2025
|
2 Sep 2025 9:51AM |
$6.720 |
$7.890 |
risen by
17.41%
|
|
| Volt Group Limited (VPR) ORDINARY FULLY PAID |
Utilities |
$25 |
Update - Notification of buy-back - VPR
|
2 Sep 2025 9:48AM |
$0.120 |
$0.150 |
risen by
25%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$42 |
Notification of cessation of securities - DCC
|
2 Sep 2025 9:48AM |
$0.067 |
$0.028 |
fallen by
58.21%
|
|
| Eastern Resources Limited (EFE) ORDINARY FULLY PAID |
Materials |
$4 |
Project update Trigg Hill
|
2 Sep 2025 9:46AM |
$0.034 |
$0.033 |
fallen by
2.94%
|
|
| Nick Scali Limited (NCK) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,179 |
Initial Director's Interest Notice - N Peiris
|
2 Sep 2025 9:42AM |
$23.980 |
$13.790 |
fallen by
42.49%
|
|
| Nick Scali Limited (NCK) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,179 |
Appointment of Non-Executive Director
|
2 Sep 2025 9:41AM |
$23.980 |
$13.790 |
fallen by
42.49%
|
|
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$45 |
Trading Halt
|
2 Sep 2025 9:39AM |
$0.220 |
$0.145 |
fallen by
34.09%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue Technologies Limited requested a trading halt on 2 September 2025.
- The halt is pending an announcement about a major product update.
- Trading halt will remain until the announcement is made or until 4 September 2025.
- ClearVue is a smart building materials company.
- No known reasons to prevent the trading halt from being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$45 |
Trading Halt
|
2 Sep 2025 9:39AM |
$0.220 |
$0.145 |
fallen by
34.09%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue Technologies Limited requests a trading halt.
- Trading halt pending a major product update announcement.
- The halt is effective immediately as of 2 September 2025.
- Trading halt to last until the announcement or 4 September 2025.
- Request made in accordance with ASX Listing Rule 17.1.
- ClearVue is not aware of any other necessary market information regarding the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HUB24 Limited (HUB) ORDINARY FULLY PAID |
Financials |
$6,885 |
2026 Financial Calendar
|
2 Sep 2025 9:39AM |
$103.770 |
$84.190 |
fallen by
18.87%
|
|
| Koonenberry gold Limited (KNB) ORDINARY FULLY PAID |
Materials |
$28 |
Appendix 4G and Corporate Governance Statement
|
2 Sep 2025 9:39AM |
$0.045 |
$0.027 |
fallen by
40%
|
|
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
- |
High-grade saprolite-hosted rutile confirmed
|
2 Sep 2025 9:39AM |
$0.300 |
$0.130 |
fallen by
56.67%
|
|
DY6 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade saprolite-hosted rutile confirmed.
- Significant rutile concentrations found across multiple drill sites.
- Commercial viability supported by assay results.
- Further exploration and development planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
- |
High-grade saprolite-hosted rutile confirmed
|
2 Sep 2025 9:39AM |
$0.300 |
$0.130 |
fallen by
56.67%
|
|
DY6 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade saprolite-hosted rutile mineralisation confirmed at Central Rutile Project.
- Rutile grades up to 2.1% at Nsimbo and 1.57% at Alamba.
- Exploration covers a 5,901 km² area in Cameroon, notable for its rutile deposits.
- 41 km strike-length of rutile mineralisation identified between Nsimbo and Alamba.
- 35% of systematic soil sampling campaign completed.
- XRF and XRD analyses confirm rutile as the dominant mineral with low ilmenite levels.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$1,975 |
4DMedical receives $6.0m R&D Tax Incentive
|
2 Sep 2025 9:38AM |
$0.775 |
$3.320 |
risen by
328.39%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical Limited received $6.0 million in R&D Tax Incentive credits.
- Strategic investment from Pro Medicus amounted to $10.0 million.
- The company's proforma cash balance is $22.9 million as of 30 June 2025.
- Potential further capital injection from exercise of 41 million options.
- XV Lung Ventilation Analysis Software predicts procedural complications with high accuracy.
- CT:VQâ„¢ commercialisation is well-positioned for rollout.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$1,975 |
4DMedical receives $6.0m R&D Tax Incentive
|
2 Sep 2025 9:38AM |
$0.775 |
$3.320 |
risen by
328.39%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical receives $6.0 million in R&D Tax Incentive credits
- Pro Medicus invests $10.0 million, elevating cash balance to $22.9 million
- Funds to support CT:VQâ„¢ rollout and product commercialization
- XV LVAS® study published, highlighting predictive capabilities in COPD treatment
- Company enhances financial position for global diagnostic tool delivery
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$98 |
LRT NAV Estimate - 31 August 2025
|
2 Sep 2025 9:37AM |
$1.700 |
$2.360 |
risen by
38.82%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$786 |
Cleansing Statement
|
2 Sep 2025 9:37AM |
$0.185 |
$0.600 |
risen by
224.32%
|
|